转甲状腺素蛋白淀粉样变心肌病经氯苯唑酸治疗6 个月1 例
孙金鹏， 程敏 - 临床心血管病杂志, 2024 - lcxxg.whuhzzs.com
… transthyretin amyloidosis, … transthyretin amyloidosis. Tafamidis is a potent drug for the
treatment of transthyretin amyloid cardiomyopathy. Early screening, diagnosis, and administration …
treatment of transthyretin amyloid cardiomyopathy. Early screening, diagnosis, and administration …
[PDF][PDF] 转甲状腺素蛋白淀粉样变心肌病的诊疗进展
罗金勇 - 中国医学创新 - zgyxcx.com
… transthyretin amyloidosis (ATTR). Due to the insidious onset of ATTR, easy misdiagnosis and
missed diagnosis… on the early clinical manifestations, diagnosis, prognosis and treatment of …
missed diagnosis… on the early clinical manifestations, diagnosis, prognosis and treatment of …
神经系统疾病RNA 靶向治疗的新进展
… , acute hepatic porphyria, and hereditary transthyretin amyloidosis, respectively. In addition,
… approach for the treatment of hereditary transthyretin amyloidosis and Huntington’s disease, …
… approach for the treatment of hereditary transthyretin amyloidosis and Huntington’s disease, …
核医学显像在心脏淀粉样变性中的应用进展
张元丽， 李慧敏， 郭小闪 - 国际放射医学核医学杂志, 2023 - ijrmnm.com
… In CA, transthyretin amyloidosis and immunoglobulin light chain amyloidosis are the most
common, and there are huge differences in the median survival time and treatment methods of …
common, and there are huge differences in the median survival time and treatment methods of …
[HTML][HTML] 心脏淀粉样变的研究进展
张昕彤， 任卫东， 张晶， 谭雪莹 - 中国医科大学学报, 2019 - html.rhhz.net
… 心脏淀粉样变主要分2种,轻链免疫球蛋白型(immunoglobulin light chain amyloidosis,AL)和
甲状腺素运载蛋白型(transthyretin amyloidosis,ATTR),其中ATTR型又分为野生型与突变型.其他…
甲状腺素运载蛋白型(transthyretin amyloidosis,ATTR),其中ATTR型又分为野生型与突变型.其他…
针对肥厚表型心肌病发病机制治疗新药研发进展
刘彦博， 田庄， 张抒扬 - 罕见病研究, 2023 - jrd.chard.org.cn
… 蛋白 等, 另有约10%的患者是由其他系统性, 遗传性, 代谢性疾病引起, 部分学者也称为HCM 拟
表型, 主 要包括: 糖原贮积症, 溶酶体贮积病, 转甲状腺素蛋 白淀粉样变(transthyretin amyloidosis…
表型, 主 要包括: 糖原贮积症, 溶酶体贮积病, 转甲状腺素蛋 白淀粉样变(transthyretin amyloidosis…
[PDF][PDF] 脓毒性心肌病发病机制及其治疗的研究进展
袁莹 - 中国医学创新, 2019 - zgyxcx.com
… transthyretin amyloidosis (ATTR). Due to the insidious onset of ATTR, easy misdiagnosis and
missed diagnosis… on the early clinical manifestations, diagnosis, prognosis and treatment of …
missed diagnosis… on the early clinical manifestations, diagnosis, prognosis and treatment of …
[PDF][PDF] 《 2023 年美国心脏病学会心脏淀粉样变性多学科管理决策路径专家共识》 解读
程震锋， 陆家葳， 沈丽英 - 心电与循环 - xdyxh.com
… 其中1 种蛋白的错误折叠引起的:(1)骨髓浆细胞 疾病产生的单克隆免疫球蛋白轻链型(monoclonal
immunoglobulin light chain amyloidosis,L);(2)转甲 状腺素蛋白(transthyretin amyloidosis,…
immunoglobulin light chain amyloidosis,L);(2)转甲 状腺素蛋白(transthyretin amyloidosis,…
临床药师参与1 例转甲状腺素蛋白淀粉样变心肌病的药物治疗实践.
甄媛媛， 张倩 - Practical Pharmacy & Clinical Remedies, 2023 - search.ebscohost.com
… between CHADS-VASc score and left atrial appendage thrombus in patients with transthyretin
amyloidosis[J]. JACC Clin Electrophysiolꎬ2019ꎬ5(12):1473-1474. [22] Mitrani LRꎬDe …
amyloidosis[J]. JACC Clin Electrophysiolꎬ2019ꎬ5(12):1473-1474. [22] Mitrani LRꎬDe …
心肌淀粉样变的诊断及治疗进展
张宁， 魏文迎， 吴颖， 王茂敬， 赵青 - 心脏杂志, 2020 - heartj.cn
… of cardiac amyloidosis, the diagnosis of cardiac amyloidosis is often overlooked in early
stage. This review is focused on early diagnosis detection and treatment improvement in light …
stage. This review is focused on early diagnosis detection and treatment improvement in light …